IntriCon’s New CDM Device (NASDAQ:IIN)

IntriCon Corporation (NASDAQ:IIN) announced that they will soon unveil a prototype of their new Cardiac Diagnostic Monitoring (CDM) device called the Mobile Patient ECG Telemetry System or MPETS. The Company has announced that they will unveil this device at the 2009 American Heart Association (AHA) Scientific Sessions which will be held in Orlando from November 15. IntriCon Corporation is one of the leading companies that designs, develops and manufactures miniature and micro-miniature body-worn medical and electronic products. The Company currently focuses on three segments which are medical, hearing health and professional audio and communications. IntriCon has announced that they will be at booth 1663 in the Orange County Convention Center where they will introduce the new MPETS device which will be a next generation wireless outpatient monitoring tool which will use the automatic arrhythmia detection algorithm.

IntriCon’s CEO and President, Mark Gorder mentioned that they are really excited to unveil this new CDM device and it will be great news for cardiac diagnostic OEMs and their patients. He further stated that they have leveraged Datrix’s cardiac monitoring capabilities and IntriCon’s marketing abilities to develop a new wireless cardiac monitoring device that provides more patient comfort and ability to identify asymptomatic cardiac events which includes atrial fibrillation, brady arrhythmia, tachy arrhythmia and cardiac pause. This new CDM device will provide IntriCon the access to the emerging biotelemetry space.